Skip to main content
Mats Sanden, MD, Pathology, Bensalem, PA, Penn Highlands DuBois

MatsOlofSandenMDMBA

Pathology • Bensalem, PA

Anatomic Pathology, Clinical Pathology

Chief Medical Officer

Join to view full profile

Dr. Sanden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sanden's full profile

Already have an account?

Summary

  • Dr. Mats Sanden is Chief Medical Officer for a clinical Laboratory in Bensalem, PA. He received his medical degree from University of Gothenburg Faculty of Medicine and has been in practice 29 years. He also speaks multiple languages, including Swedish. He specializes in molecular pathology, molecular oncology diagnostics, anatomic pathology, and clinical pathology.

Education & Training

  • George Washington Umniversity
    George Washington UmniversityMBA, Business Administration, 2011 - 2013
  • Washington Hospital Center
    Washington Hospital CenterResidency, Pathology-Anatomic and Clinical, 1993 - 1997
  • Univ of Gothenburg- Fac Med
    Univ of Gothenburg- Fac MedClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2019 - 2024
  • NY State Medical License
    NY State Medical License 2011 - 2024
  • PA State Medical License
    PA State Medical License 1996 - 2024
  • NV State Medical License
    NV State Medical License 2023 - 2023
  • NC State Medical License
    NC State Medical License 2022 - 2023
  • NJ State Medical License
    NJ State Medical License 1998 - 2023
  • FL State Medical License
    FL State Medical License 2018 - 2023
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilizing fine needle aspirate smears  
    Gila Lithwick-Yanai, Nir Dromi, Alexander Shtabsky , Sara Morgenstern, Yulia Strenov , Meora Feinmesser Vladimir Kravtsov , Marino E Leon, Marián Hajdúch, Syed Z Ali, ..., J Clin Pathology, 10/26/2016
  • Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown p...  
    Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H, Meiri E, Chajut A, Rosenwald S, Aharonov ..., Mol Cancer, 6/10/2013
  • Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinoma  
    Yael Spector, Eddie Fridman, Shai Rosenwald, Sofia Zilber,Yajue Huang, Iris Barshack, Orit Zion, Heather Mitchell, Mats Sanden, Eti Meiri, Mol Oncol, 3/26/2013
  • Join now to see all

Professional Memberships

Other Languages

  • Swedish

Hospital Affiliations

Dr. Mats Sanden, Dr. Mats Sanden, MD, Dr. M Sanden, Dr. Mats Olof Sanden